Structure | Chemical Name | CAS | MF |
|
Cyclopropanecarboxylic acid, 1-(carboxyamino)-, monomethyl ester (9CI)
|
162873-03-2
|
C6H9NO4
|
|
5,9-Methanocyclooctathiazole(9CI)
|
162873-26-9
|
C10H7NS
|
|
coat protein, potato virus Y
|
162875-27-6
|
|
|
glycoprotein G, murine pneumonia virus
|
162876-50-8
|
|
|
5-Thiazolecarboxylicacid,2,4-diamino-(9CI)
|
162880-44-6
|
C4H5N3O2S
|
|
Phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide
|
162881-26-7
|
C26H27O3P
|
|
4-BENZYLOXY-ALPHA-CYANOCINNAMIC ACID
|
162882-36-2
|
C17H13NO3
|
|
1-((3R,10S,13S,17S)-3-hydroxy-3-(methoxymethyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone
|
162882-64-6
|
C23H38O3
|
|
(+/-)-EPIBATIDINE DIHYDROCHLORIDE
|
162885-01-0
|
C11H15Cl3N2
|
|
4-Bromo-1,2-pyrazolidinedicarboxaldehyde
|
162887-23-2
|
C5H7BrN2O2
|
|
ISOSTEARYL HYDROXYSTEARATE
|
162888-05-3
|
C36H72O3
|
|
2(5H)-Furanone,4-hydroxy-5-methoxy-5-(1-methylethyl)-(9CI)
|
162892-99-1
|
C8H12O4
|
|
2-HYDROXYETHANE-1-SULFONAMIDE
|
162894-76-0
|
C2H7NO3S
|
|
1-Propen-1-ol,2-(2-pyridinyl)-,(Z)-(9CI)
|
162894-98-6
|
C8H9NO
|
|
4-Pyridineacetaldehyde,alpha-methyl-(9CI)
|
162894-99-7
|
C8H9NO
|
|
2-Pyridineacetaldehyde,alpha-methyl-(9CI)
|
162895-00-3
|
C8H9NO
|
|
Oxazolidine, 3-methyl-2-(1-methylethyl)-, (S)- (9CI)
|
162897-66-7
|
C7H15NO
|
|
CALIX[4]-BIS-2,3-NAPHTHO-CROWN-6
|
162898-44-4
|
C64H64O12
|
|
(S)-3-(4'-BENZYLOXYPHENYL)-2-HYDROXY-PROPIONIC ACID
|
162919-37-1
|
C16H16O4
|
|
[2-(TRIFLUOROMETHYL)PHENOXY]ACETIC ACID
|
162922-18-1
|
C9H7F3O3
|
|
Epocholeone
|
162922-31-8
|
C35H56O7
|
|
C-TELOPEPTIDE
|
162929-64-8
|
C34H56N14O13
|
|
5-(5-CHLORO-2-METHOXYPHENYL)-5-OXOVALERIC ACID
|
162930-56-5
|
C12H13ClO4
|
|
Ethanone, 1-(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,2-trifluoro-, (R)- (9CI)
|
162932-23-2
|
C7H9F3O3
|
|
naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone
|
162934-73-8
|
C20H21NO
|
|
1-Hexyl-3-(1-naphthoyl)pyrrole
|
162934-74-9
|
C21H23NO
|
|
naphthalen-1-yl(1H-pyrrol-3-yl)methanone
|
162934-76-1
|
C15H11NO
|
|
PROPYPHENAZONE-D3 (2-N-METHYL-D3)
|
162935-29-7
|
C14H15D3N2O
|
|
2-IODO-5'-ETHYLCARBOXAMIDO-2',3'-O-ISOPROPYLIDINEADENOSINE
|
162936-24-5
|
C15H19IN6O4
|
|
2H-Benzimidazol-2-imine,1,3-dihydro-(9CI)
|
162938-41-2
|
C7H7N3
|
|
(S)-(-)-N-Boc-2-Amino-1,5-pentanediol
|
162955-48-8
|
C10H21NO4
|
|
(S)-(-)-2-(BOC-AMINO)-1,5-PENTANEDIOL
|
162955-48-8
|
C10H21NO4
|
|
Butanedioic acid, 2-cyano-3-(2-oxoethyl)-, dimethyl ester (9CI)
|
162956-90-3
|
C9H11NO5
|
|
4-(4-Hydroxyphenyl)benzyl alcohol
|
162957-24-6
|
C13H12O2
|
|
6-Benzothiazolecarboxylicacid,2,3-dihydro-2-thioxo-,methylester(9CI)
|
162959-43-5
|
C9H7NO2S2
|
|
1-(thiophen-2-yl)cyclopropanecarbonitrile
|
162959-93-5
|
C8H7NS
|
|
1-(thien-2-yl)cyclopropanecarboxylic acid
|
162959-94-6
|
C8H8O2S
|
|
Cyclopropanecarboxylic acid, 1-(2-furanyl)- (9CI)
|
162960-09-0
|
C8H8O3
|
|
1-(PYRIDIN-2-YL)CYCLOPROPANECARBOXYLIC ACID
|
162960-26-1
|
C9H9NO2
|
|
Cyclopropanecarbonitrile, 1-(2-pyridinyl)- (9CI)
|
162960-28-3
|
C9H8N2
|
|
N-(benzo[d][1,3]dioxol-5-ylmethyl)-1H-tetrazol-5-amine
|
162961-18-4
|
C9H9N5O2
|
|
2-[(2,2,2-TRIFLUOROETHYL)THIO]-PYRIDINE
|
162965-54-0
|
C7H6F3NS
|
|
5,8-Dibromo-2,3-bis(4-methoxyphenyl)quinoxaline
|
162967-90-0
|
C22H16Br2N2O2
|
|
Dexamethasone Sodium Phosphate EP Impurity H
|
162968-22-1
|
C22H30FO8P-2
|
|
1,2,4-Oxadiazole-3-carboximidamide,N-hydroxy-5-methyl-
|
162969-65-5
|
C4H6N4O2
|
|
2(1H)-Pyridinethione, 1-(2-phenylethyl)-
|
162970-15-2
|
C13H13NS
|
|
2(1H)-Pyridinethione, 1-(1,1-dimethylethyl)-
|
162970-18-5
|
C9H13NS
|
|
2(1H)-Pyridinethione, 1-(2-azidoethyl)-
|
162970-31-2
|
C7H8N4S
|
|
2-Pyrrolidinone,3,3-difluoro-(9CI)
|
162970-49-2
|
C4H5F2NO
|
|
2-Pyrrolidinone,3,3-difluoro-1-methyl-(9CI)
|
162970-50-5
|
C5H7F2NO
|
|
2-Hydroxy-3-(2-methyl-2-propenyl)benzaldehyde
|
162971-77-9
|
C11H12O2
|
|
SALOR-INT L300888-1EA
|
162976-08-1
|
C12H16O3
|
|
Carbamic acid, (1,3-dihydro-2H-benzimidazol-2-ylidene)-, methyl ester (9CI)
|
162976-69-4
|
C9H9N3O2
|
|
THALLIUM HYDROTRIS(INDAZOL-2-YL)BORATE
|
162978-03-2
|
C21H16BN6Tl
|
|
Cyclopropanecarboxylic acid, 1-amino-2-chloro-, (1R-trans)- (9CI)
|
162989-67-5
|
C4H6ClNO2
|
|
RITONAVIR
|
162990-01-4
|
C37H48N6O5S2
|
|
CARBAMIC ACID, [(1S,2S,4S)-4-AMINO-2-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL]-, 5-THIAZOLYLMETHYL ESTER, DIHYDROCHLORIDE
|
162990-03-6
|
C23H27N3O3S.2ClH
|
|
2,5-Piperazinedione,1,3,6-trimethyl-,(3R-trans)-(9CI)
|
162990-28-5
|
C7H12N2O2
|
|
(S)-6-DIPROPYLAMINO-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-OL HYDROBROMIDE
|
162992-70-3
|
C16H25NO
|
|
Oxirane, polymer with 1,6-diisocyanatohexane, stearyl alc.-blocked
|
162993-60-4
|
|
|
1-(4-cyanophenyl)piperidine-4-carboxylic acid
|
162997-21-9
|
C13H14N2O2
|
|
1-BOC-4-(4'-CYANOPHENYL)PIPERIDINE
|
162997-33-3
|
C17H22N2O2
|
|
4-(PIPERIDIN-4-YL)BENZONITRILE HYDROCHLORIDE
|
162997-34-4
|
C12H15ClN2
|
|
4-[4-(Hydroxymethyl)piperidin-1-yl]benzonitrile
|
162997-46-8
|
C13H16N2O
|
|
6,7-dihydro-5H-Pyrrolo[1,2-a]iMidazole-3-carboxylic acid ethyl ester
|
163000-06-4
|
C9H12N2O2
|
|
4-Heptenal, 6-oxo-, (4E)- (9CI)
|
163000-36-0
|
C7H10O2
|
|
Nebostinel
|
163000-63-3
|
C13H24N2O3
|
|
Cyclobutane, 1,1,2,3,3-pentafluoro- (9CI)
|
163002-47-9
|
C4H3F5
|
|
4-(TRANS-4-PROPYLCYCLOHEXYL)-2-FLUORO-4''-METHYLBIPHENYL
|
163005-08-1
|
C22H27F
|
|
2-Fluoro-4-(trans-4-pentylcyclohexyl)phenylboronic acid
|
163006-96-0
|
C17H26BFO2
|
|
4-METHYL-1,2,3-THIADIAZOLE-5-METHANOL
|
163008-86-4
|
C4H6N2OS
|
|
4-(CHLOROMETHYL)-1H-PYRAZOLE HYDROCHLORIDE
|
163008-98-8
|
C4H6Cl2N2
|
|
4-(1,2,4-OXADIAZOL-3-YL)-1,2,5-OXADIAZOL-3-AMINE
|
163011-56-1
|
C4H3N5O2
|
|
1,2,5-Oxadiazole-3-carboximidamide,N-(acetyloxy)-4-amino-
|
163011-64-1
|
C5H7N5O3
|
|
4 5-BENZO-5'-(CARBOXYMETHYL)-1'-ETHYL-3&
|
163016-50-0
|
C37H42N2O5S
|
|
Mono(6-phenylaMino-6-deoxy)-beta-cyclodextrin
|
163016-93-1
|
C48H75NO34
|
|
25-Hydroxy Vitamin D3 3,3’-Aminopropyl Ether
|
163018-26-6
|
C30H51NO2
|
|
2-(Benzenesulfonyl)-N,N-diethylacetamide
|
163019-28-1
|
C12H17NO3S
|
|
5,6,7,8,9,10-hexahydro-4-hydroxy-3-(1-phenylpropyl)-2H-cycloocta(b)pyran-2-one
|
163020-88-0
|
C20H24O3
|
|
4-(5,6-DIMETHOXYBENZOTHIAZOL-2-YL)BENZOIC ACID HYDRAZIDE
|
163032-69-7
|
C16H15N3O3S
|
|
NOR-1
|
163032-70-0
|
C8H13N3O5
|
|
NOR-2
|
163032-71-1
|
C7H11N3O4
|
|
DPS-CL
|
163032-72-2
|
C16H14ClNO5S
|
|
9-CYANO-N,N,N'-TRIETHYLPYRONINE-N'-CAPROIC ACID N 4-(MALEIMIDOETHYL)PIPERAZIDE CHLORIDE
|
163032-73-3
|
C36H45ClN6O4
|
|
Dimethyl 2-propylmalonate
|
163033-62-3
|
C8H14O4
|
|
3-ETHYL-4-OXO-10-OXA-3-AZA-TRICYCLO[5.2.1.0(1,5)]DEC-8-ENE-6-CARBOXYLIC ACID
|
163035-51-6
|
C11H13NO4
|
|
2,2-Difluoroethyl mesylate
|
163035-65-2
|
C3H6F2O3S
|
|
2-Hexanone, 3-hydroxy-5-methyl- (9CI)
|
163038-04-8
|
C7H14O2
|
|
(Z)-Methyl 2-iodo-3-Methoxyacrylate
|
163041-47-2
|
C5H7IO3
|
|
4-TETRAHYDROPYRANOXY-2-METHOXYBENZALDEHYDE
|
163041-68-7
|
C13H16O4
|
|
3,8-Tetradecadien-1-ol, acetate, (3E,8Z)- (9CI)
|
163041-87-0
|
C16H28O2
|
|
E3,Z8,Z11-Tetradecatriene acetate
|
163041-94-9
|
C16H26O2
|
|
Hexadecanamide, N-[(1R,2R)-2-hydroxy-2-phenyl-1-(1-pyrrolidinylmethyl)ethyl]-
|
163042-29-3
|
C29H50N2O2
|
|
Hexadecanamide, N-[(1R,2R)-2-hydroxy-2-(4-methoxyphenyl)-1-(1-pyrrolidinylmethyl)ethyl]-
|
163042-37-3
|
C30H52N2O3
|
|
4-METHYLPIPERAZINYL PHENYLCYCLOPENTYL KETONE
|
163042-59-9
|
C17H24N2O
|
|
1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE
|
163042-96-4
|
C18H18ClIN6O4
|
|
3-CYCLOHEXYL-4-METHYLTHIOPHENE
|
163045-78-1
|
C11H16S
|
|
(Ile76)-TNF-α (70-80) (human)
|
163045-82-7
|
C55H91N15O16
|
|
CIMICIFUGOSIDE H-1
|
163046-73-9
|
C35H52O9
|
|
Anemarrhenasaponin-I
|
163047-21-0
|
C39H66O14
|